BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22269932)

  • 1. Impact of the bundled end-stage renal disease payment system on patient care.
    Maddux FW
    Blood Purif; 2012; 33(1-3):107-11. PubMed ID: 22269932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can we learn from the U.S. expanded end-stage renal disease bundle?
    Chambers JD; Weiner DE; Bliss SK; Neumann PJ
    Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).
    Brunelli SM; Monda KL; Burkart JM; Gitlin M; Neumann PJ; Park GS; Symonian-Silver M; Yue S; Bradbury BD; Rubin RJ
    Am J Kidney Dis; 2013 Jun; 61(6):947-56. PubMed ID: 23332991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care.
    Winkelmayer WC
    Blood Purif; 2011; 31(1-3):66-9. PubMed ID: 21228569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare programs: changes to the end-stage renal disease prospective payment system transition budget-neutrality adjustment. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Apr; 76(66):18930-4. PubMed ID: 21491804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH; Sapolsky HM
    Inquiry; 1987; 24(1):57-67. PubMed ID: 2951335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
    Park H; Rascati KL; Keith MS
    J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initial impact of Medicare's new prospective payment system for kidney dialysis.
    Hirth RA; Turenne MN; Wheeler JR; Nahra TA; Sleeman KK; Zhang W; Messana JA
    Am J Kidney Dis; 2013 Oct; 62(4):662-9. PubMed ID: 23769138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisions in the end stage renal disease prospective payment system: implications for nephrology nurses.
    Wish D
    Nephrol Nurs J; 2009; 36(6):635-41. PubMed ID: 20050516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare ESRD prospective payment system: weighing the evidence.
    Himmelfarb J; Chertow GM
    J Am Soc Nephrol; 2005 May; 16(5):1164-5. PubMed ID: 15829705
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.
    Wetmore JB; Tzivelekis S; Collins AJ; Solid CA
    BMC Nephrol; 2016 May; 17(1):53. PubMed ID: 27228981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes and alternatives for dialysis facilities under the bundled payment plan.
    Solid CA; Collins AJ
    Nephrol News Issues; 2013 May; 27(6):30-2. PubMed ID: 23729081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare pilot program on bundled payments to health care providers could be the next PPS for dialysis.
    Levy R
    Nephrol News Issues; 2012 Feb; 26(2):37-8. PubMed ID: 22439371
    [No Abstract]   [Full Text] [Related]  

  • 19. The 2011 ESRD prospective payment system: welcome to the bundle.
    Weiner DE
    Am J Kidney Dis; 2011 Apr; 57(4):539-41. PubMed ID: 21333431
    [No Abstract]   [Full Text] [Related]  

  • 20. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
    Lacson E; Hakim RM
    Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.